BR100 Decreased By (-0.19%)
BR30 Decreased By (-0.42%)
KSE100 Decreased By (-0.09%)
KSE30 Decreased By (-0.01%)
AGHA 6.64 Decreased By ▼ -0.03 (-0.45%)
BECO 4.37 Increased By ▲ 0.02 (0.46%)
BML 55.11 Decreased By ▼ -1.06 (-1.89%)
BOP 29.98 Decreased By ▼ -0.14 (-0.46%)
CNERGY 12.71 Decreased By ▼ -0.27 (-2.08%)
CSIL 5.20 Decreased By ▼ -0.11 (-2.07%)
FCCL 51.68 Increased By ▲ 0.03 (0.06%)
FFL 14.43 Decreased By ▼ -0.06 (-0.41%)
FNEL 1.19 Decreased By ▼ -0.02 (-1.65%)
KEL 6.02 Decreased By ▼ -0.04 (-0.66%)
KOSM 5.44 Decreased By ▼ -0.40 (-6.85%)
LOTCHEM 26.10 Decreased By ▼ -0.07 (-0.27%)
MLCF 91.15 Decreased By ▼ -0.08 (-0.09%)
NBP 162.30 Decreased By ▼ -1.89 (-1.15%)
NCPL 52.55 Decreased By ▼ -0.63 (-1.18%)
NPL 57.94 Decreased By ▼ -1.18 (-2%)
OGDC 314.95 Increased By ▲ 1.56 (0.5%)
PACE 9.75 Decreased By ▼ -0.02 (-0.2%)
PAEL 35.00 Decreased By ▼ -0.24 (-0.68%)
PIBTL 14.30 Decreased By ▼ -0.41 (-2.79%)
PPL 220.39 Decreased By ▼ -0.97 (-0.44%)
PRL 89.87 Decreased By ▼ -1.35 (-1.48%)
PTC 59.40 Increased By ▲ 0.21 (0.35%)
SSGC 23.28 Decreased By ▼ -0.02 (-0.09%)
TBL 8.66 Decreased By ▼ -0.09 (-1.03%)
TELE 7.43 Decreased By ▼ -0.18 (-2.37%)
TPL 21.10 Decreased By ▼ -0.93 (-4.22%)
TPLP 12.17 Decreased By ▼ -0.39 (-3.11%)
TREET 21.58 Decreased By ▼ -0.15 (-0.69%)
TRG 55.15 Decreased By ▼ -0.64 (-1.15%)

LAHORE: Nearly 34.5 million people are living with diabetes, while around 38 million live with obesity in Pakistan, significantly impacting individuals, families, communities and healthcare system.

Novo Nordisk Pakistan marked a significant milestone in its commitment to shaping the future of healthcare in Pakistan by leading a delegation of key stakeholders to Copenhagen, Denmark. The delegation included representatives from government bodies, healthcare associations and policy decision-making forums.

The Knowledge Exchange initiative was a pioneering effort, reflecting Novo Nordisk’s commitment to working alongside healthcare professionals to drive meaningful and lasting improvements to people living with serious chronic diseases such as diabetes and obesity.

The program provided participants exposure to Denmark’s advanced healthcare ecosystem, allowing the delegation to witness and explore innovative approaches for tackling diabetes and obesity, with an emphasis on early interventions and improved patient care. The visitors engaged in dialogue centred on practical pathways to localize these learning, enabling their adaptation to Pakistan’s unique healthcare needs to drive better patient outcomes and support system-level reforms.

Rashid Rafique Butt, General Manager of Novo Nordisk Pakistan, emphasizing the urgent need for action said: “Diabetes and obesity are among the fastest-growing health challenges in the country, and healthcare professionals are central to addressing them. Through this collaboration, we aimed to empower healthcare professionals with insights and tools to elevate standards of care, secure long-term health, and create healthier communities. This initiative underscores our enduring commitment and confidence to driving change in Pakistan through innovation and sustainable solutions that support the country’s healthcare system and shape its future.”

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.